Study of Azacitidine to Evaluate Safety and Effectiveness for Chinese Patients With Higher Risk Myelodysplastic Syndrome
Clinical trial NCT01599325 · COMPLETED
Trial details
- NCT number
- NCT01599325
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-24
- Primary completion
- 2015-01-29
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.